文献速递脑血管病外科

散发性脑动静脉畸形的MAPK通路体细胞嵌合与表型关联

Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
PubMed 文献 · J Neurosurg · 2021-07-02

该研究对14例散发性脑动静脉畸形患者的病灶与配对血液DNA行全外显子测序,评估MAPK通路295个基因的体细胞突变,并用微滴数字PCR在额外56例样本中验证KRAS G12V/G12D。结果显示KRAS G12V见于14.5%病灶、G12D见于31.9%,未发现KRAS突变与病灶最大直径、诊断年龄或ICH年龄显著相关。

要点

  • 散发性BAVM病灶中KRAS体细胞突变常见,G12D频率高于G12V。
  • 未发现KRAS突变存在或等位基因负荷与病灶大小、诊断年龄或ICH年龄相关。
  • 其他MAPK通路基因的候选体细胞变异可能参与散发性BAVM病因。

核心结论

  • 研究证实散发性BAVM病灶中KRAS体细胞突变高发,并识别出其他MAPK通路基因的候选体细胞变异。
  • KRAS突变的 presence 或 allelic burden 与病灶最大直径、诊断年龄及ICH年龄无显著关联。

研究设计与样本

  • 对14例散发性BAVM患者的配对病灶与血液DNA行全外显子测序,评估MAPK信号通路295个基因。
  • 采用微滴数字PCR验证KRAS G12V和G12D突变,并检测额外56例BAVM样本。

主要发现

  • 在11个MAPK通路基因中鉴定出24个候选BAVM相关体细胞变异,仅KRAS G12V和G12D为复发性突变。
  • KRAS G12V存在于14.5%的BAVM病灶,KRAS G12D存在于31.9%的BAVM病灶。
  • 未检测到KRAS突变的存在或等位基因负荷与病灶大小(最大直径)、诊断年龄、ICH年龄三个BAVM表型之间存在显著关联。

临床怎么用

  • 对散发性BAVM病灶可考虑评估KRAS G12V/G12D等体细胞突变,以辅助理解病因。
  • 当前KRAS突变状态不宜用于预测病灶大小、诊断年龄或ICH年龄等临床表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sporadic brain arteriovenous malformation (BAVM) is a tangled vascular lesion characterized by direct artery-to-vein connections that can cause life-threatening intracerebral hemorrhage (ICH). Recently, somatic mutations in KRAS have been reported in sporadic BAVM, and mutations in other mitogen-activated protein kinase (MAPK) signaling pathway genes have been identified in other vascular malformations. The objectives of this study were to systematically evaluate somatic mutations in MAPK pathway genes in patients with sporadic BAVM lesions and to evaluate the association of somatic mutations with phenotypes of sporadic BAVM severity. METHODS: The authors performed whole-exome sequencing on paired lesion and blood DNA samples from 14 patients with sporadic BAVM, and 295 genes in the MAPK signaling pathway were evaluated to identify genes with somatic mutations in multiple patients with BAVM. Digital droplet polymerase chain reaction was used to validate KRAS G12V and G12D mutations and to assay an additional 56 BAVM samples. RESULTS: The authors identified a total of 24 candidate BAVM-associated somatic variants in 11 MAPK pathway genes. The previously identified KRAS G12V and G12D mutations were the only recurrent mutations. Overall, somatic KRAS G12V was present in 14.5% of BAVM lesions and G12D was present in 31.9%. The authors did not detect a significant association between the presence or allelic burden of KRAS mutation and three BAVM phenotypes: lesion size (maximum diameter), age at diagnosis, and age at ICH. CONCLUSIONS: The authors confirmed the high prevalence of somatic KRAS mutations in sporadic BAVM lesions and identified several candidate somatic variants in other MAPK pathway genes. These somatic variants may contribute to understanding of the etiology of sporadic BAVM and the clinical characteristics of patients with this condition.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Gao S, Nelson J, Weinsheimer S, et al. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype. J Neurosurg. 2021. PMID: 34214981. doi:10.3171/2020.11.JNS202031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。